Develops clinically validated, patented probiotic blends and diagnostic biomarkers for atopic dermatitis, psoriasis, acne, COVID‑19 digestive symptoms, multiple sclerosis prediction and early head‑and‑neck cancer diagnosis. Targets pharmaceutical partners, patent licensees and organizations seeking contract research (CRO) services.